Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 21.64 billion. The enterprise value is 22.26 billion.
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jun 18, 2026 |
Share Statistics
Zhende Medical has 263.88 million shares outstanding. The number of shares has decreased by -1.90% in one year.
| Current Share Class | 263.88M |
| Shares Outstanding | 263.88M |
| Shares Change (YoY) | -1.90% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 10.47% |
| Owned by Institutions (%) | 3.24% |
| Float | 102.60M |
Valuation Ratios
The trailing PE ratio is 72.48 and the forward PE ratio is 44.09.
| PE Ratio | 72.48 |
| Forward PE | 44.09 |
| PS Ratio | 4.65 |
| PB Ratio | 3.77 |
| P/TBV Ratio | 5.36 |
| P/FCF Ratio | 163.34 |
| P/OCF Ratio | 45.09 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 31.39, with an EV/FCF ratio of 168.03.
| EV / Earnings | 75.50 |
| EV / Sales | 4.78 |
| EV / EBITDA | 31.39 |
| EV / EBIT | 57.76 |
| EV / FCF | 168.03 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.70 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 2.00 |
| Debt / FCF | 10.71 |
| Interest Coverage | 13.65 |
Financial Efficiency
Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is 5.14%.
| Return on Equity (ROE) | 5.00% |
| Return on Assets (ROA) | 2.85% |
| Return on Invested Capital (ROIC) | 5.14% |
| Return on Capital Employed (ROCE) | 5.79% |
| Weighted Average Cost of Capital (WACC) | 6.71% |
| Revenue Per Employee | 588,559 |
| Profits Per Employee | 37,274 |
| Employee Count | 7,909 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.72 |
Taxes
In the past 12 months, Zhende Medical has paid 54.89 million in taxes.
| Income Tax | 54.89M |
| Effective Tax Rate | 15.47% |
Stock Price Statistics
The stock price has decreased by -7.44% in the last 52 weeks. The beta is 0.51, so Zhende Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -7.44% |
| 50-Day Moving Average | 80.92 |
| 200-Day Moving Average | 85.12 |
| Relative Strength Index (RSI) | 48.92 |
| Average Volume (20 Days) | 804,329 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.65 billion and earned 294.80 million in profits. Earnings per share was 1.13.
| Revenue | 4.65B |
| Gross Profit | 1.56B |
| Operating Income | 385.35M |
| Pretax Income | 354.75M |
| Net Income | 294.80M |
| EBITDA | 704.29M |
| EBIT | 385.35M |
| Earnings Per Share (EPS) | 1.13 |
Full Income Statement Balance Sheet
The company has 1.06 billion in cash and 1.42 billion in debt, with a net cash position of -360.13 million or -1.36 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 1.42B |
| Net Cash | -360.13M |
| Net Cash Per Share | -1.36 |
| Equity (Book Value) | 6.00B |
| Book Value Per Share | 21.76 |
| Working Capital | 1.30B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 479.89 million and capital expenditures -347.42 million, giving a free cash flow of 132.47 million.
| Operating Cash Flow | 479.89M |
| Capital Expenditures | -347.42M |
| Depreciation & Amortization | 318.94M |
| Net Borrowing | -37.98M |
| Free Cash Flow | 132.47M |
| FCF Per Share | 0.50 |
Full Cash Flow Statement Margins
Gross margin is 33.57%, with operating and profit margins of 8.28% and 6.33%.
| Gross Margin | 33.57% |
| Operating Margin | 8.28% |
| Pretax Margin | 7.62% |
| Profit Margin | 6.33% |
| EBITDA Margin | 15.13% |
| EBIT Margin | 8.28% |
| FCF Margin | 2.85% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.37%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.37% |
| Dividend Growth (YoY) | -53.85% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 37.41% |
| FCF Payout Ratio | 59.76% |
| Buyback Yield | 1.90% |
| Shareholder Yield | 2.27% |
| Earnings Yield | 1.38% |
| FCF Yield | 0.61% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Zhende Medical has an Altman Z-Score of 6.79 and a Piotroski F-Score of 8.
| Altman Z-Score | 6.79 |
| Piotroski F-Score | 8 |